Premium
Skin permeation, biodistribution, and expression of topically applied plasmid DNA
Author(s) -
Kang MinJeong,
Kim ChongKook,
Kim Mi Young,
Hwang Tae Sun,
Kang Sang Yoon,
Kim WonKi,
Ko Jung Jae,
Oh YuKyoung
Publication year - 2004
Publication title -
the journal of gene medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.689
H-Index - 91
eISSN - 1521-2254
pISSN - 1099-498X
DOI - 10.1002/jgm.620
Subject(s) - plasmid , in vivo , dna , microbiology and biotechnology , biodistribution , in vitro , chemistry , real time polymerase chain reaction , human skin , biology , gene , biochemistry , genetics
Background Topical application is emerging as a new route of gene delivery. However, the extent of skin permeation and the in vivo fate of topically applied plasmid DNA are not fully understood. Methods In vitro permeation of plasmid DNA across human skin and keratinocyte layers was tested using Franz diffusion cells. In vivo absorption and biodistribution of topically applied plasmid in mice were determined using quantitative polymerase chain reaction (PCR). The expression levels of plasmid DNA in various tissues were measured by semiquantitative reverse transcription PCR. Results In vitro , topically applied DNA was capable of penetrating human skin and keratinocyte layers. Following topical application of plasmid DNA onto murine skin, the levels of plasmid DNA in the serum peaked at 4 hr. At 24 hr post‐dose, topically applied DNA existed at higher levels than intravenously administered DNA in almost all tissues, and induced 11.4‐ and 22‐fold higher mRNA expression in muscle and skin, respectively. Moreover, the topical route showed sustained expression of plasmid DNA in the regional lymph nodes over 5 days, whereas the intravenous route did not. Conclusions Taken together, our results show that topically applied plasmid DNA is capable of permeating the skin and being expressed for prolonged periods in various tissues including lymph nodes. This suggests that skin may provide an appealing, noninvasive route of delivery for DNA vaccines and other therapeutic genes. Copyright © 2004 John Wiley & Sons, Ltd.